Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term RO0503821 for chronic renal anemia
2004-002032-26Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2004
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of epoetin beta in anemia of renal disease, sponsored by Roche. Primary endpoint: Analysis of Efficacy. Started Nov 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2004-002032-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002032-26.